Andrea Loewen, SVP, Global Regulatory Affairs at REATA PHARMACEUTICALS INC (RETA), sold 3,420 shares at $87.73 ($301K) on 2023-03-03, disclosed to the SEC on 2023-03-06.
Open-market sale of $301k RETA by SVP, Global Regulatory Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.61 | 218 | $20K | 6.6% |
| 2 | $87.73 | 1,601 | $140K | 46.7% |
| 3 | $87.73 | 1,601 | $140K | 46.7% |
| Total | $87.91 avg | 3,420 | $301K | 100% |
| Filing → |
| RETA | SELL | 2023-03-09 | $3.1M | — | Filing → |